A Comparison of Pharmacodynamics When Receiving a Double Dose of Insulin Peglispro or Insulin Glargine in Patients With Type 2 Diabetes Mellitus: A Double-Blind, Crossover Design Study
Phase of Trial: Phase III
Latest Information Update: 25 Apr 2018
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Registrational
- Acronyms IMAGINE 8
- Sponsors Eli Lilly
- 15 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 May 2015 Planned End Date changed from 1 Aug 2015 to 1 Jul 2015, as reported by ClinicalTrials.gov.
- 14 May 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Jul 2015, as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History